Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A patient with BRAF V600E lung adenocarcinoma responding to vemurafenib.
Gautschi O, Pauli C, Strobel K, Hirschmann A, Printzen G, Aebi S, Diebold J. Gautschi O, et al. Among authors: strobel k. J Thorac Oncol. 2012 Oct;7(10):e23-4. doi: 10.1097/JTO.0b013e3182629903. J Thorac Oncol. 2012. PMID: 22743296 Free article. No abstract available.
A patient with lung adenocarcinoma and RET fusion treated with vandetanib.
Gautschi O, Zander T, Keller FA, Strobel K, Hirschmann A, Aebi S, Diebold J. Gautschi O, et al. Among authors: strobel k. J Thorac Oncol. 2013 May;8(5):e43-4. doi: 10.1097/JTO.0b013e31828a4d07. J Thorac Oncol. 2013. PMID: 23584301 Free article. No abstract available.
Lung adenocarcinoma with BRAF G469L mutation refractory to vemurafenib.
Gautschi O, Peters S, Zoete V, Aebersold-Keller F, Strobel K, Schwizer B, Hirschmann A, Michielin O, Diebold J. Gautschi O, et al. Among authors: strobel k. Lung Cancer. 2013 Nov;82(2):365-7. doi: 10.1016/j.lungcan.2013.08.012. Epub 2013 Aug 19. Lung Cancer. 2013. PMID: 24035431
248 results